NO153141C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-aza-17-substituert-5alfa-androstan-3-oner. - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-aza-17-substituert-5alfa-androstan-3-oner.

Info

Publication number
NO153141C
NO153141C NO791220A NO791220A NO153141C NO 153141 C NO153141 C NO 153141C NO 791220 A NO791220 A NO 791220A NO 791220 A NO791220 A NO 791220A NO 153141 C NO153141 C NO 153141C
Authority
NO
Norway
Prior art keywords
5alfa
oner
androstan
aza
substituted
Prior art date
Application number
NO791220A
Other languages
English (en)
Norwegian (no)
Other versions
NO153141B (no
NO791220L (no
Inventor
David Bruce Randolph Johnston
Gary Henry Rasmusson
Donald Floyd Reinhold
Ronald Bradford Jobson
Torleif Utne
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO791220L publication Critical patent/NO791220L/no
Publication of NO153141B publication Critical patent/NO153141B/no
Publication of NO153141C publication Critical patent/NO153141C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0016Oximes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J11/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J3/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J33/00Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/005Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton spiro-condensed
    • C07J33/007Cyclic thioketals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0066Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by a carbon atom forming part of an amide group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J73/00Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/16Benz[e]indenes; Hydrogenated benz[e]indenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO791220A 1978-04-13 1979-04-10 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-aza-17-substituert-5alfa-androstan-3-oner. NO153141C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/896,120 US4179453A (en) 1978-04-13 1978-04-13 Process for preparing 17β-carboxy-5-androsten-3-ones

Publications (3)

Publication Number Publication Date
NO791220L NO791220L (no) 1979-10-16
NO153141B NO153141B (no) 1985-10-14
NO153141C true NO153141C (no) 1986-01-22

Family

ID=25405660

Family Applications (1)

Application Number Title Priority Date Filing Date
NO791220A NO153141C (no) 1978-04-13 1979-04-10 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-aza-17-substituert-5alfa-androstan-3-oner.

Country Status (11)

Country Link
US (1) US4179453A (xx)
AR (7) AR231991A1 (xx)
AT (1) AT377767B (xx)
DK (2) DK165325C (xx)
ES (1) ES479576A1 (xx)
FI (1) FI67389C (xx)
GR (1) GR68531B (xx)
NO (1) NO153141C (xx)
PL (2) PL223577A1 (xx)
PT (1) PT69451A (xx)
YU (1) YU86879A (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5237061A (en) * 1988-10-31 1993-08-17 Merck & Co., Inc. Methods of synthesizing benign prostatic hypertropic agents and their intermediates
US4970205A (en) * 1988-12-23 1990-11-13 Smithkline Beecham Corporation Sulfonic acid substituted aromatic steroids as inhibitors of steroid 5-α-reductase
US4937237A (en) * 1988-12-23 1990-06-26 Smithkline Beckman Corporation Phosphinic acid substituted aromatic steroids as inhibitors of steroid 5-60 -reductase
US5360881A (en) * 1989-06-14 1994-11-01 Societe Francaise Hoechst Method of cross-linking ethylene monomers using diallyloxyacetic acid and its basic addition salts as cross-linking agents
IE76452B1 (en) * 1990-10-29 1997-10-22 Sankyo Co Azasteroid compounds for the treatment of prostatic hypertrophy their preparation and use
FR2724174B1 (fr) * 1994-09-06 1997-01-17 Roussel Uclaf Procede de preparation d'un derive steroide 17beta-carboxy et nouveaux intermediaires

Also Published As

Publication number Publication date
AR224011A1 (es) 1981-10-15
DK165325C (da) 1993-03-29
AR231991A1 (es) 1985-04-30
AT377767B (de) 1985-04-25
GR68531B (xx) 1982-01-14
DK92192D0 (da) 1992-07-15
DK165325B (da) 1992-11-09
DK92192A (da) 1992-07-15
PL126826B1 (en) 1983-09-30
PT69451A (en) 1979-05-01
PL214881A1 (xx) 1981-12-11
YU86879A (en) 1983-10-31
PL223577A1 (xx) 1981-11-27
NO153141B (no) 1985-10-14
NO791220L (no) 1979-10-16
US4179453A (en) 1979-12-18
AR225045A1 (es) 1982-02-15
AR241488A1 (es) 1992-07-31
ES479576A1 (es) 1979-12-01
FI67389C (fi) 1985-03-11
AR222391A1 (es) 1981-05-15
FI791193A (fi) 1979-10-14
FI67389B (fi) 1984-11-30
ATA275079A (de) 1984-09-15
DK152579A (da) 1979-10-14
AR228037A1 (es) 1983-01-14
AR222390A1 (es) 1981-05-15

Similar Documents

Publication Publication Date Title
NO150760C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotiazoler.
NO154058C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-heterocyklyl-4-piperidinaminer.
NO155055C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-carbolin-3-carboxylsyrederivater.
NO158679C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 2-penem-3-karboksylsyreforbindelser.
NO792787L (no) Fremgangsmaate ved fremstilling av antiinflammatorisk aktive 4,5-diaryl-2-nitroimidazoler
NO155774C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazo-diazepin-derivater.
NO155290C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme sulfonylurinstoffderivater.
NO794069L (no) Fremgangsmaate ved fremstilling av terapeutisk virksomme imidayolderivater.
NO151588C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamid-derivater
NO812344L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive steroider.
NO152213C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte benzazepiner
NO810675L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NO153569C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacetyl-prolin-derivater.
NO152007C (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme 7beta-(syn-2-oksyimino-arylacetamido)-3-(sulfoalkyltetrazol-5-yl-tiometyl)-cephem-4-karboksylsyrer
NO157976C (no) Analogifremgangsm te ved fremstilling av terapeutisk aktive 3-fenoxy-1-azetidincarboxamider.
NO151239C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-fenyliminoimidazolidiner
NO781878L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner.
NO152787C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenyl-kinolizidiner.
NO156167C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinon-derivater.
NO158800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indenderivater.
NO151660C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolderivater.
NO152128C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-amino-3-benzoylfenylacetamider
NO153141C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-aza-17-substituert-5alfa-androstan-3-oner.
NO146863C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive alkyltiofenoksyalkylaminer
NO151008C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nitroforbindelser